As expected, the pro-inflammatory cytokine TNF-α was highly expressed in glioblastoma cells, and its expression was significantly reduced following BCP treatment, probably as a consequence of NF-κB reduction and PPAR-γ activation. Here, NFKB1 is linked to glioblastoma.